[
  {
    "title": "百诚医药(301096.SZ)：拟使用3.64亿元超募资金永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2022/12/15175737215682.shtml",
    "datetime": "2022-12-15 17:57:59",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)：拟使用不超4.5亿元闲置募资暂时补充流动资金",
    "href": "http://stock.jrj.com.cn/2022/12/15175637215690.shtml",
    "datetime": "2022-12-15 17:56:38",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)：4265.57万股限售股12月20日解禁",
    "href": "http://stock.jrj.com.cn/2022/12/15174837215635.shtml",
    "datetime": "2022-12-15 17:48:29",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)：拟向银行申请不超7.5亿元综合授信额度",
    "href": "http://stock.jrj.com.cn/2022/11/22195737158648.shtml",
    "datetime": "2022-11-22 19:57:59",
    "code": "301096"
  },
  {
    "title": "百诚医药2022年前三季度净利1.45亿同比增长125.08% 订单充足",
    "href": "http://stock.jrj.com.cn/2022/10/25205037083241.shtml",
    "datetime": "2022-10-25 20:50:57",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)第三季度净利6020.05万元 同比增长155.42%",
    "href": "http://stock.jrj.com.cn/2022/10/25195737082934.shtml",
    "datetime": "2022-10-25 19:57:50",
    "code": "301096"
  },
  {
    "title": "A股异动 | 百诚医药(301096.SZ)涨4.8% 拟投5亿元建医美(健康)产品等项目",
    "href": "http://stock.jrj.com.cn/2022/09/26100937020427.shtml",
    "datetime": "2022-09-26 10:09:05",
    "code": "301096"
  },
  {
    "title": "百诚医药：子公司拟5亿元投建创新药物及研发中心等项目",
    "href": "http://stock.jrj.com.cn/2022/09/26092137020267.shtml",
    "datetime": "2022-09-26 09:21:27",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)：拟投资5亿元建创新药物、高端复杂制剂、医美(健康)产品CMO、CDMO及研发中心项目",
    "href": "http://stock.jrj.com.cn/2022/09/23193637018160.shtml",
    "datetime": "2022-09-23 19:36:42",
    "code": "301096"
  },
  {
    "title": "百诚医药净利润翻倍有余：受托研发与自主转化并重 医药专业“夫妻店 ”打造全产业链",
    "href": "http://stock.jrj.com.cn/2022/08/16193236905517.shtml",
    "datetime": "2022-08-16 19:32:36",
    "code": "301096"
  },
  {
    "title": "百诚医药：2022年半年实现营收2.46亿元，同比增长73.91%",
    "href": "http://stock.jrj.com.cn/2022/08/10144736886469.shtml",
    "datetime": "2022-08-10 14:47:48",
    "code": "301096"
  },
  {
    "title": "百诚医药2022上半年业绩出炉：研发人员月薪5000元 货币资金减少5亿元",
    "href": "http://stock.jrj.com.cn/2022/08/10121136886061.shtml",
    "datetime": "2022-08-10 12:11:01",
    "code": "301096"
  },
  {
    "title": "A股异动 | 百诚医药一度涨超8% 上半年净利增长翻倍",
    "href": "http://stock.jrj.com.cn/2022/08/10095836885536.shtml",
    "datetime": "2022-08-10 09:58:22",
    "code": "301096"
  },
  {
    "title": "百诚医药2022年上半年净利8502.13万同比增长107.62% 新增订单金额增长",
    "href": "http://stock.jrj.com.cn/2022/08/09221036884613.shtml",
    "datetime": "2022-08-09 22:10:37",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)：上半年净利润增107.62%至8502.13万元",
    "href": "http://stock.jrj.com.cn/2022/08/09193336884021.shtml",
    "datetime": "2022-08-09 19:33:55",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)：拟出资500万元认购股权投资基金份额",
    "href": "http://stock.jrj.com.cn/2022/07/08183236795361.shtml",
    "datetime": "2022-07-08 18:32:09",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)：向197名激励对象首次授予248.3261万股第二类限制性股票",
    "href": "http://stock.jrj.com.cn/2022/06/22221436751239.shtml",
    "datetime": "2022-06-22 22:14:19",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)：138.7232万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2022/06/15204136732502.shtml",
    "datetime": "2022-06-15 20:41:04",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)：拟推2022年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/06/06194536706853.shtml",
    "datetime": "2022-06-06 19:45:48",
    "code": "301096"
  },
  {
    "title": "百诚医药2022年第一季度净利1952.98万同比增长352.57% 业务规模持续扩大",
    "href": "http://stock.jrj.com.cn/2022/05/03191136546529.shtml",
    "datetime": "2022-05-03 19:11:47",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)一季度净利润1952.98万元 同比增长352.57%",
    "href": "http://stock.jrj.com.cn/2022/04/25183336465666.shtml",
    "datetime": "2022-04-25 18:33:15",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)2021年度权益分派10派6元 股权登记日为4月15日",
    "href": "http://stock.jrj.com.cn/2022/04/12152536315034.shtml",
    "datetime": "2022-04-12 15:25:35",
    "code": "301096"
  },
  {
    "title": "A股异动 | 百诚医药(301096.SZ)一度涨超10% 2021年度净利润升93.52%",
    "href": "http://stock.jrj.com.cn/2022/03/15135434828542.shtml",
    "datetime": "2022-03-15 13:54:39",
    "code": "301096"
  },
  {
    "title": "百诚医药2021年净利1.11亿同比增长93.52% 董事长楼金芳薪酬119.96万",
    "href": "http://stock.jrj.com.cn/2022/03/14223434826184.shtml",
    "datetime": "2022-03-14 22:34:06",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)2021年度净利润升93.52%至1.11亿元 拟10派6元",
    "href": "http://stock.jrj.com.cn/2022/03/14201234825667.shtml",
    "datetime": "2022-03-14 20:12:37",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)：拟1000万元参投私募基金杭州晓池",
    "href": "http://stock.jrj.com.cn/2022/03/09180934578968.shtml",
    "datetime": "2022-03-09 18:09:00",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)：创新药BIOS-0618片获批临床，治疗神经病理性疼痛",
    "href": "http://stock.jrj.com.cn/2022/02/07182834302577.shtml",
    "datetime": "2022-02-07 18:28:31",
    "code": "301096"
  },
  {
    "title": "百诚医药2021年预计净利9900万-1.1亿同比增长72%-92% 新增订单金额增长",
    "href": "http://stock.jrj.com.cn/2022/01/25181234213152.shtml",
    "datetime": "2022-01-25 18:12:08",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)2021年度净利润预增72.46%-91.63%",
    "href": "http://stock.jrj.com.cn/2022/01/25161034210108.shtml",
    "datetime": "2022-01-25 16:10:46",
    "code": "301096"
  },
  {
    "title": "【龙虎榜】百诚医药12月20日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/12/20180334035340.shtml",
    "datetime": "2021-12-20 18:03:13",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)IPO认购结果：网上网下共弃购17.318万股",
    "href": "http://stock.jrj.com.cn/2021/12/14210534016206.shtml",
    "datetime": "2021-12-14 21:05:12",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)：回拨后网上发行的中签率为0.0168%",
    "href": "http://stock.jrj.com.cn/2021/12/09205233991465.shtml",
    "datetime": "2021-12-09 20:52:27",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)IPO定价为79.6元/股 12月9日申购",
    "href": "http://stock.jrj.com.cn/2021/12/07205733981594.shtml",
    "datetime": "2021-12-07 20:57:12",
    "code": "301096"
  },
  {
    "title": "百诚医药(301096.SZ)：网上路演时间为12月8日14:00-17:00",
    "href": "http://stock.jrj.com.cn/2021/12/06212833975564.shtml",
    "datetime": "2021-12-06 21:28:48",
    "code": "301096"
  },
  {
    "title": "证监会同意百诚医药、光庭信息、凯旺科技创业板IPO注册",
    "href": "http://stock.jrj.com.cn/2021/11/10171433835261.shtml",
    "datetime": "2021-11-10 17:14:00",
    "code": "301096"
  },
  {
    "title": "百诚医药过会：今年IPO过关第170家 国金证券过7单",
    "href": "http://stock.jrj.com.cn/2021/06/10093532903803.shtml",
    "datetime": "2021-06-10 09:35:00",
    "code": "301096"
  },
  {
    "title": "创业板第30次审议会议结出炉：星源卓镁、百诚医药首发过会",
    "href": "http://stock.jrj.com.cn/2021/06/09225332901938.shtml",
    "datetime": "2021-06-09 22:53:55",
    "code": "301096"
  },
  {
    "title": "星源卓镁、欣巴科技、百诚医药将于6月9日创业板上会",
    "href": "http://stock.jrj.com.cn/2021/06/03135132868935.shtml",
    "datetime": "2021-06-03 13:51:00",
    "code": "301096"
  },
  {
    "title": "营收规模相对较小 百诚医药拟募资6.51亿元闯关创业板IPO | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/11/23204531334131.shtml",
    "datetime": "2020-11-23 20:45:30",
    "code": "301096"
  },
  {
    "title": "百诚医药创业板IPO获受理：去年净利润同比增长292.36%",
    "href": "http://stock.jrj.com.cn/2020/11/18190231309358.shtml",
    "datetime": "2020-11-18 19:02:12",
    "code": "301096"
  }
]